Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh

NARecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

April 29, 2021

Primary Completion Date

March 30, 2026

Study Completion Date

December 30, 2027

Conditions
Hernia, VentralHernia, Inguinal
Interventions
DEVICE

OviTex Reinforced Tissue Matrix

All study subjects will receive OviTex. All OviTex Reinforced Tissue Matrices are intended for use as a surgical mesh to reinforce or repair soft tissue where weakness exists.

Trial Locations (10)

11576

WITHDRAWN

St. Francis Hospital, Roslyn

13502

RECRUITING

Mohawk Valley Health System, Utica

33912

TERMINATED

Surgical Healing Arts Center, Fort Myers

36617

RECRUITING

University of South Alabama, Mobile

40202

RECRUITING

University of Louisville, Louisville

49684

RECRUITING

Munson Healthcare, Traverse City

66213

RECRUITING

St. Luke's Hospital, Overland Park

77030

ACTIVE_NOT_RECRUITING

Houston Methodist, Houston

325541

TERMINATED

GenesisCare, Destin

802210

ACTIVE_NOT_RECRUITING

SurgOne, Denver

All Listed Sponsors
collaborator

MCRA

INDUSTRY

lead

Tela Bio Inc

INDUSTRY